Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
Inorganic ion
Predicted metabolite or user's structure
Generic receptor
Receptors with enzyme activity

Normal process
Pathological process
Covalent modifications
Transcription regulation
MicroRNA binding
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Immune response IL-6 signaling pathway

Log In to Post A Comment

Immune response IL-6 signaling pathway

IL-6 signaling pathway

Interleukin-6 ( IL-6 ) is a pleiotropic cytokine produced by various types oflymphoid and nonlymphoid cells, such as T cells, B cells, monocytes, fibroblasts,keratinocytes, endothelial cells, mesangial cells and several tumor cells. IL-6provokes a broad range of cellular and physiological responses, including the immuneresponse, inflammation, hematopoiesis and oncogenesis by regulating cell growth, geneactivation, proliferation, survival and differentiation [1].

IL-6 signals through IL-6 receptor composed of two differentsubunits, Interleukin 6 receptor alpha subunit ( IL6RA ) that produces ligandspecificity and Interleukin 6 signal transducer ( gp130 ), a receptor subunitshared with other cytokines of the IL-6 family [2].

Binding of IL-6 to its receptor initiates cellular events including activationof Janus kinase 1 ( JAK1 )/ Signal transducer and activator of transcription 3 (STAT3 ) and Extracellular signal-regulated kinase 1 and 2 ( ERK1/2 )signaling pathways [3], [4], [5].

Activated JAK1 phosphorylates STAT3, which dimerizes and istranslocated to the nucleus to activate transcription of genes containing STAT3response elements [6], [7], [3].

Up-regulation of Suppressor of cytokine signaling 3 ( SOCS3 ) genetranscription by STAT3 leads to the termination of IL-6 cytokine signaling[8], [9], [10], [11].

JAK1 is also required for the tyrosine phosphorylation of Protein tyrosinephosphatase non-receptor type 11 ( SHP-2 ) that associates with SHC transformingprotein 1 ( Shc ) and Growth factor receptor-bound protein 2 ( GRB2 )followed by activation of the ERK1/2 signaling [12], [13],[14], [15], [4].

Shc/ GRB2/ Son of sevenless homologs ( SOS )/ v-Ha-ras Harveyrat sarcoma viral oncogene homolog ( H-Ras )/ v-Raf-1 murine leukemia viraloncogene homolog 1 ( c-Raf-1 )/ Mitogen-activated protein kinase kinase 1 and 2 (MEK1 and MEK2 )/ ERK1/2 pathway activates transcription factors suchas ELK1 member of ETS oncogene family ( Elk-1 ) and CCAAT/enhancer binding proteinbeta ( C/EBPbeta ) that act through their own cognate response elements in thegenome [16], [17], [1], [18], [19], [20]. These factors and other transcription factors, includingv-Fos FBJ murine osteosarcoma viral oncogene homolog ( c-Fos ), Jun oncogene (c-Jun ) and Serum response factor ( SRF ) regulate a variety of complexpromoters and enhancers that respond to IL-6 [21], [22],[23], [24], [25], [5].

c-Jun and c-Fos also cooperate with STAT3 in IL-6 -inducedtransactivation of target gene promoters containing IL-6 response element (IRE) [26], [27]. In turn, STAT3 can induce c-Fos geneexpression in response to IL-6 [18].

IL-6 activates cells by binding to the membrane-bound IL6RA andsubsequent formation of a complex with gp130 homodimer. Cells that expressgp130, but not IL6RA, can be activated by IL-6 and the solubleIL6RA which is produced by shedding from the cell surface by metalloproteinasesADAM17 and ADAM10 [28], [29].

In response to a variety of signals, such as bacterial pathogens, Interleukin-1 beta(IL-1 beta), Tumor necrosis factor alpha (TNF-alpha), Transforming growth factor, beta 1(TGF-beta 1) etc., IL-6 gene expression is up-regulated by a wide range oftranscription factors, including Nuclear factor-kappa B ( NF-kB ),C/EBPbeta, CCAAT/enhancer binding protein delta ( C/EBPdelta ), cAMPresponsive element binding protein 1 ( CREB1 ), Jun D proto-oncogene ( junD), v-Fos FBJ murine osteosarcoma viral oncogene homolog ( c-Fos ), Jun oncogene (c-Jun ), depending on cell type and ligand specificity [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41].

The feedback inhibition of IL-6 gene expression by glucocorticoids represents aregulatory link between the endocrine and immune systems. Ligand-activated Glucocorticoidreceptor ( GCR-alpha ) represses the IL-6 gene transcription by occlusionnot only of the inducible IL-6 enhancer region but also of the basal IL-6promoter elements [42], [43].